Document Detail

Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests.
MedLine Citation:
PMID:  22844659     Owner:  NLM     Status:  In-Data-Review    
Heart failure is a leading cause of morbidity and mortality in the Western world. It is often a progressive disease, and the pathophysiology behind this adverse development is not completely understood. Biomarkers are of increasing importance in heart failure research. Despite a growing number of candidate markers, only a select few have made it into clinical practice. Interleukin-1 receptor-like 1 (IL1RL1), also known as protein ST2, is the receptor for interleukin-33 (IL-33), a cytokine involved in T-cell-mediated immune responses. IL1RL1 expression is induced by cardiomyocyte stretch, and IL1RL1 may thus reflect the activity of two interacting processes in heart failure: inflammation and hemodynamic stress. In recent years, the soluble, truncated IL1RL1 isoform B has been shown to provide prognostic information in heart failure. Although ILRL1 isoform B does not seem to aid in the diagnosis of the disease, an elevated plasma/serum concentration of this marker is firmly associated with adverse outcome in patients with heart failure. This association has been established in different heart failure cohorts and is independent of age, etiology of heart failure and left ventricular function. Ultimately, the IL-33/IL1RL1 pathway may become a therapeutic target in heart failure.
K Broch; T Ueland; A Yndestad; P Aukrust; L Gullestad
Related Documents :
10779459 - Frequency and clinical implications of fluid dynamically significant diffuse coronary a...
1202079 - The relationship between regional myocardial perfusion at rest and arteriographic lesio...
22833549 - Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibr...
18273659 - Model prediction of subendocardial perfusion of the coronary circulation in the presenc...
17208989 - Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independe...
18562719 - Quantification of myocardial perfusion by contrast-enhanced 64-mdct: characterization o...
8537149 - Involvement of inducible nitric oxide synthase in the inflammatory process of myocardia...
2485029 - Physiologic versus pathologic hypertrophy and the pressure-overloaded myocardium.
23629679 - Effects of angiotensin ii blockade on cardiomyocyte regeneration after myocardial infar...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drugs of today (Barcelona, Spain : 1998)     Volume:  48     ISSN:  1699-3993     ISO Abbreviation:  Drugs Today     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160518     Medline TA:  Drugs Today (Barc)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  479-91     Citation Subset:  IM    
Copyright Information:
Copyright 2012 Prous Science, S.A.U. or its licensors. All rights reserved.
Department of Cardiology, Oslo University Hospital, Rikshospitalet, and Faculty of Medicine, University of Oslo, Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
Next Document:  A report from the American Society of Hypertension's 2012 annual scientific meeting and exposition (...